Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-12-28 5:06 pm Purchase | 2023-12-28 | 13G | Arcellx, Inc. ACLX | GILEAD SCIENCES INC. GILD | 6,720,803 12.900% | 3,242,542 (+93.22%) | Filing History |
| 2023-12-22 4:18 pm Purchase | 2023-12-20 | 13G | HOOKIPA Pharma Inc. HOOK | GILEAD SCIENCES INC. GILD | 1,875,947 19.400% | 1,500,000 (+398.99%) | Filing History |
| 2023-10-25 5:18 pm Purchase | 2023-10-16 | 13D | Assembly Biosciences, Inc. ASMB | GILEAD SCIENCES INC. GILD | 1,089,472 19.900% | 1,089,472 (New Position) | Filing History |
| 2023-10-19 3:33 pm Purchase | 2023-10-11 | 13G | Ikena Oncology, Inc. IKNA | GILEAD SCIENCES INC. GILD | 2,931,467 6.700% | 2,931,467 (New Position) | Filing History |
| 2023-07-06 09:38 am Purchase | 2023-06-28 | 13D | Arcus Biosciences, Inc. RCUS | GILEAD SCIENCES INC. GILD | 25,586,953 35.000% | 2,863,797 (+12.60%) | Filing History |
| 2023-02-14 2:06 pm Unchanged | 2022-03-24 | 13G | HOOKIPA Pharma Inc. HOOK | GILEAD SCIENCES INC. GILD | 375,947 7.200% | 0 (Unchanged) | Filing History |
| 2023-02-13 3:32 pm Sale | 2023-02-14 | 13G | Gilead Sciences, Inc. GILD | Capital Research Global Investors | 54,602,952 4.400% | -52,554,029 (-49.04%) | Filing History |
| 2023-02-13 2:49 pm Purchase | 2023-02-14 | 13G | Gilead Sciences, Inc. GILD | Capital World Investors | 68,900,998 5.500% | 12,538,508 (+22.25%) | Filing History |
| 2023-02-09 11:19 am Purchase | 2022-12-30 | 13G | Gilead Sciences, Inc. GILD | The Vanguard Group | 112,038,324 8.930% | 6,234,525 (+5.89%) | Filing History |
| 2023-02-06 4:05 pm Purchase | 2023-01-26 | 13G | Arcellx, Inc. ACLX | GILEAD SCIENCES INC. GILD | 3,478,261 7.300% | 3,478,261 (New Position) | Filing History |
| 2023-01-31 08:55 am Purchase | 2022-12-31 | 13G | Gilead Sciences, Inc. GILD | BlackRock Inc. BLK | 131,555,769 10.500% | 4,623,076 (+3.64%) | Filing History |
| 2022-08-05 5:52 pm Purchase | 2022-07-28 | 13G | AlloVir, Inc. ALVR | GILEAD SCIENCES INC. GILD | 595,844 14.800% | 595,844 (New Position) | Filing History |
| 2022-07-08 4:56 pm Purchase | 2022-06-30 | 13G | Gilead Sciences, Inc. GILD | BlackRock Inc. BLK | 126,932,693 10.100% | 7,971,487 (+6.70%) | Filing History |
| 2022-02-17 2:43 pm Purchase | 2022-02-15 | 13G | HOOKIPA Pharma Inc. HOOK | GILEAD SCIENCES INC. GILD | 375,947 12.900% | 166,667 (+79.64%) | Filing History |
| 2022-02-17 2:11 pm Unchanged | 2021-12-31 | 13G | Agenus Inc. AGEN | GILEAD SCIENCES INC. GILD | 566,111 4.300% | 0 (Unchanged) | Filing History |
| 2022-02-11 12:22 pm Sale | 2022-02-14 | 13G | Gilead Sciences, Inc. GILD | Capital Research Global Investors | 107,156,981 8.500% | -14,515,418 (-11.93%) | Filing History |
| 2022-02-10 4:55 pm Purchase | 2021-12-31 | 13G | Sierra Oncology, Inc. SRRA | GILEAD SCIENCES INC. GILD | 1,450,566 9.200% | 377,266 (+35.15%) | Filing History |
| 2022-02-10 4:51 pm Sale | 2021-04-20 | 13G | Allogene Therapeutics, Inc. ALLO | GILEAD SCIENCES INC. GILD | 1,156,689 0.800% | -6,330,000 (-84.55%) | Filing History |
| 2022-02-10 4:50 pm Unchanged | 2021-12-31 | 13G | Agenus Inc. AGEN | GILEAD SCIENCES INC. GILD | 566,111 4.300% | 0 (Unchanged) | Filing History |
| 2022-02-10 08:11 am Purchase | 2021-12-31 | 13G | Gilead Sciences, Inc. GILD | The Vanguard Group | 105,803,799 8.430% | 3,016,782 (+2.93%) | Filing History |